Jaguar Health (JAGX) Amortization of Deferred Charges (2014 - 2026)

Jaguar Health (JAGX) has 12 years of Amortization of Deferred Charges data on file, last reported at $47000.0 in Q1 2026.

• On a quarterly basis, Amortization of Deferred Charges fell 29.85% year-over-year to $47000.0 in Q1 2026; TTM through Mar 2026 was $133000.0, a 42.67% decrease from a year earlier, with the FY2025 full-year figure at $153000.0, down 44.16% from the prior year.
• Amortization of Deferred Charges for Q1 2026 stood at $47000.0, up from -$70000.0 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for JAGX reached as high as $3.4 million in Q1 2022 and fell as low as -$8.5 million in Q4 2022.
• Historically, Amortization of Deferred Charges has averaged $68235.3 across 5 years, with a median of $89000.0 in 2023.
• On a YoY basis, Amortization of Deferred Charges climbed as much as 205.95% in 2022 and fell as far as 265.43% in 2022.
• Year by year, Amortization of Deferred Charges stood at -$8.5 million in 2022, then surged by 101.05% to $89000.0 in 2023, then plunged by 177.53% to -$69000.0 in 2024, then fell by 1.45% to -$70000.0 in 2025, then surged by 167.14% to $47000.0 in 2026.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $47000.0 in Q1 2026, -$70000.0 in Q4 2025, and $78000.0 in Q3 2025.